Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

GPI-15427 improves function of poorly preserved livers in animal model

June 16, 2003

Novel cholecystokinin CCK2 antagonists and their use in gastrin-related disorders

June 12, 2003

New alpha4 integrin antagonists and their use in IBD, asthma, arthritis, etc.

June 11, 2003

Nabi receives complete response for Nabi-HB

June 10, 2003

Enrollment completed in phase III alvimopan study in postoperative ileus

June 10, 2003

Nuvion development targeted for ulcerative colitis

June 5, 2003

SR-140333B effective and well tolerated in ulcerative colitis

June 3, 2003

Asimadoline reduces pain threshold associated with colon distension in IBS

June 3, 2003

Rigel researchers present novel anti-HCV agents

June 3, 2003

New phase II trial evaluates ISIS-14803 in HCV

June 2, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...